SCHEMBL4247388

SCHEMBL4247388

CCOc1ccccc1OC1CCNCC1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 5/20 0.57
HTR1A P08908 5/20 0.56
SLC6A2 P23975 5/20 0.56
SLC6A3 Q01959 3/20 0.56
ADRA2A P08913 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
SLC6A4 P31645 2/20 0.48
HTR2A P28223 2/20 0.48
ADRB2 P07550 1/20 0.48
ADRA1A P35348 1/20 0.48
HTR2B P41595 1/20 0.48
HTR2C P28335 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11066851 0.84 HRH1 (0.50) HRH1HTR1ASLC6A2SLC6A3SLC6A4
SCHEMBL17077450 0.81 SLC6A2 (0.50) HTR1ASLC6A2SLC6A3ADRA2AADRA2B
SCHEMBL17077451 0.81 SLC6A2 (0.50) HTR1ASLC6A2SLC6A3ADRA2AADRA2B
Ethylene SCHEMBL27549603 0.81 ALDH1A1 (0.56) HTR1AADRA2AADRA2BADRA2CKDM4E
SCHEMBL1780546 0.81 HRH1 (0.62) HRH1HTR1ASLC6A2SLC6A3SLC6A4
Hydrochloric Acid SCHEMBL23582983 0.80 SLC6A2 (0.49) HTR1ASLC6A2SLC6A3ADRA2AADRA2B
Hydrochloric Acid SCHEMBL17077567 0.80 SLC6A2 (0.49) HTR1ASLC6A2SLC6A3ADRA2AADRA2B
SCHEMBL28754655 0.80 SLC6A2 (0.55) HTR1ASLC6A2SLC6A3SLC6A4HTR2A
Ethylene SCHEMBL27857573 0.80 ALDH1A1 (0.55) HTR1AADRA2AADRA2BADRA2CKDM4E
Hydrochloric Acid SCHEMBL4100905 0.79 HRH1 (0.60) HRH1HTR1ASLC6A2SLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170901-A1 Benzoyl Urea Derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2009-07-02 US disclosed
EP-1771429-A1 NEW BENZOYL UREA DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2007-04-11 EP disclosed
WO-2006010966-A1 NEW BENZOYL UREA DERIVATIVES Richter Gedeon Vegyészeti Gyár Rt. (HU) 2006-02-02 WO disclosed
EP-1328514-A1 AMIDE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2003-07-23 EP disclosed
WO-2002034718-A1 AMIDE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2002-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170901-A1 Benzoyl Urea Derivatives OPRM1, GRIN2C, GRIN3A HRH1 42/4885HTR1A 373/4885SLC6A2 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.